At the Heart of Addressing Health Equity: A Closer Look at Janssen Pharmaceuticals Initiative for Peripheral Artery Disease (PAD)
Dr. Richard Browne, MD, FACC, Senior Medical Executive, Health Systems Strategy and the Leader of the Cardiovascular Health Equity Advisory Council for Janssen and Pamela Price-Parker, a Health and Physical Education Teacher and PAD patient advocate, discuss Janssen Pharmaceutical’s health equity initiative, Save Legs, Change Lives™ a multi-year initiative focused on creating awareness, urgency and action around the hidden threat of peripheral artery disease (PAD) related amputation, with an initial focus on Black Americans, who are up to 4X more likely to undergo a PAD-related amputation versus white Americans. Dr. Browne will discuss PAD, the signs and symptoms of the disease, and his personal connection to PAD. Pam will share her personal story as a patient living with PAD and provides advice to people and communities placed at increased risk of the disease. Since the campaign launched earlier this year, Save Legs. Change Lives™ has actioned more than 12 programs across three focus areas: empowering individuals and communities placed at an increased risk of PAD, collaborating with powerful partners, and driving research. Learn more at www.savelegschangelives.com
Richard Browne, MD, FACC, is the Senior Medical Executive, Health Systems Strategy and the Leader of the Health Equity Advisory Council for Janssen Cardiovascular and Metabolism Medical Affairs. In his role, Dr. Browne leverages his deep knowledge and expertise to lead collaborations with executive leadership at US healthcare systems, also known as integrated delivery networks (IDNs), in their efforts to achieve the quintuple aim (i.e. improving the quality of cardiovascular care, promoting cost effectiveness, enhancing the patient and health care provider experiences and striving to eliminate health disparities).
Dr. Browne graduated cum laude from Boston University School of Medicine. He then completed an internship and residency at Brigham and Women’s Hospital, the major teaching hospital of Harvard Medical School. He remained on staff as an attending physician at Harvard Medical School before completing his fellowship in cardiovascular medicine at the University of Virginia, where he served as chief cardiology fellow in his final year.
After finishing his fellowship in cardiology, he moved to Charlotte, North Carolina to begin his career as a clinical cardiologist at Sanger Heart and Vascular Institute and Atrium Health. During his tenure there, he served as Medical Director and was directly involved in the planning and execution of strategic plans for the cardiovascular division of the organization. He also participated in several cardiovascular clinical trials during that time. His role involved spending a significant amount of time educating and lecturing to medical residents and students on all aspects of cardiovascular medicine. Dr. Browne then became a senior cardiologist at Novant Health Heart and Vascular Institute at Presbyterian Medical Center in Charlotte, North Carolina.
Dr. Browne previously served as the team cardiologist for the Charlotte Hornets of the National Basketball Association for several years. During that time, he worked with the National Basketball Association on the formulation of protocols to ensure the safety of their athletes.
Dr. Browne currently serves as a council member of the North Carolina Chapter of the American College of Cardiology. In this position, he is actively involved in the formulation of strategies to reduce health care disparities in cardiovascular patients.
